23 results
8-K
EX-99.1
GUTS
Fractyl Health Inc.
24 Jun 24
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
6:04am
on third parties for the manufacture of the materials for its Rejuva gene therapy platform for preclinical studies and its ongoing clinical studies
10-Q
2024 Q1
EX-10.9
GUTS
Fractyl Health Inc.
13 May 24
Quarterly report
4:06pm
or respective customers, production of legal materials, software development and design, business or software architecture, software not yet known … , transactions, regulatory affairs, discoveries, inventions, methods, processes, articles, materials, algorithms, formulas, specifications, designs
10-Q
2024 Q1
EX-10.8
GUTS
Fractyl Health Inc.
13 May 24
Quarterly report
4:06pm
under Applicable Laws or a Party's bona fide document retention or archival policies, each Party shall return all documents and tangible materials … to the destruction of such documents and tangible materials. Notwithstanding the foregoing, Client shall have access to and shall continue to use the Platform until
10-Q
2024 Q1
GUTS
Fractyl Health Inc.
13 May 24
Quarterly report
4:06pm
manufacturing materials for use in preclinical and clinical studies and, for any product candidates for which we receive regulatory approval, use … engage in the off-label promotion of our products.
If we obtain approval or certification for any product candidates, our promotional materials
8-K
EX-99.1
GUTS
Fractyl Health Inc.
13 May 24
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
4:01pm
certain aspects of the Company’s preclinical studies and clinical studies; the Company’s reliance on third parties for the manufacture of the materials
10-K
leyexy175iwischf4yy
1 Apr 24
Annual report
7:15am
8-K
EX-3.2
s6zgwm2
6 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B4
1nxc852 5weq9bg
2 Feb 24
Prospectus supplement with pricing info
4:18pm
S-1/A
52m0hcvnr092324af6b0
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
EX-10.9
ubd7uaf46u1mm wb5w
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
EX-3.4
ke8mhcya4x 6noez4b09
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
EX-1.1
wkr7c 2loqa
29 Jan 24
IPO registration (amended)
6:09am
S-1
3lsjk7dq
14 Dec 23
IPO registration
3:39pm
S-1
EX-10.1
x5lzp qfgqo
14 Dec 23
IPO registration
3:39pm
S-1
EX-10.11
brvabns7
14 Dec 23
IPO registration
3:39pm
S-1
EX-10.10
s7sh7
14 Dec 23
IPO registration
3:39pm
DRS/A
ihmc3g
21 Sep 23
Draft registration statement (amended)
12:00am
DRS/A
p5bqej9v34
22 Aug 23
Draft registration statement (amended)
12:00am
D
r72t6tg7id5069w
25 Jan 22
$20.08M in debt, sold $20.08M, 4 investors
12:07pm
D
wogr jkjjo4hfy5o
22 Jun 21
$100M in equity, sold $100M, 15 investors
12:34pm